This CME conference is a unique medical meeting that brings world-renowned clinical leaders in diabetes and cardiovascular disease together with practicing clinicians to improve the care of patients at high risk of cardiovascular, metabolic, and kidney diseases. This program is designed to evaluate the clinical science aspects of diabetes, obesity, and CVD, focusing on the heart and kidney in diabetes. The goal is to develop appropriate comprehensive clinical management plans aligning endocrinologists, cardiologist and nephrologists in their understandings of the impact of diabetes and CVD outcome trials on the clinical management of these very high-risk patients.